Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

LUPIN LTD.

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & DrugsHouse : Lupin

BSE2114.1033.75 (+1.62 %)

PREV CLOSE ( ) 2080.35

OPEN PRICE ( ) 2085.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 12360

TODAY'S LOW / HIGH ( )2081.80 2117.10

52 WK LOW / HIGH ( )1774 2403.45

NSE2113.9032.1 (+1.54 %)

PREV CLOSE( ) 2081.80

OPEN PRICE ( ) 2083.00

BID PRICE (QTY) 2113.90 (5)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 574240

TODAY'S LOW / HIGH( ) 2080.00 2117.20

52 WK LOW / HIGH ( )1795.2 2402.9

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 01-03 1983

Management Info

Manju D Gupta - Chairman Nilesh Gupta - Managing Director

Registered Office

Address Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East),
Mumbai,
Maharashtra-400055

Phone 022 66402323

Email info@lupin.com

Website www.lupin.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

12Dec Lupin’s arm collaborates with PolyPept
Lupin’s subsidiary -- Lupin Manufacturing Solutions (LMS) has collaborat..

12Dec Lupin informs about press release
Lupin has informed that it enclosed press release titled ‘Lupin Manufact..

10Dec Lupin informs about allotment of ESOP
Lupin has informed that the Operations and Finance Committee of the Comp..

05Dec Lupin gets USFDA’s tentative approval
Lupin has received tentative approval from the United States Food and Dr..

05Dec Lupin moves up on getting USFDA’s tent
Lupin is currently trading at Rs. 2096.50, up by 4.55 points or 0.22% fr..

Financials

Rs. in Millions

	QTR Sep 25	ANNUAL 25
Net Profit	13573.5	39729.6
Gross Profit	16358.1	48371.2
Operating Profit	12456.3	56465.3
Net Sales	40682.8	169675

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Bharat Parenterals (BSE) 1128.80 (6.39%)	M.Cap ( in Cr)777.96
Amrutanjan Healthcar (BSE) 689.65 (6.38%)	M.Cap ( in Cr)1993.82
Panacea Biotec (BSE) 362.70 (9.53%)	M.Cap ( in Cr)2221.56
Emcure Pharma (BSE) 1439.60 (2.18%)	M.Cap ( in Cr)27289.76
Aurobindo Pharma (BSE) 1193.70 (1.81%)	M.Cap ( in Cr)69330.29

Shareholding Pattern

	PROMOTERS	46.9%
	MUTUAL FUNDS/UTI	20.57%
	NON-INSTITUTION	6.06%
	FI/BANKS/INSURANCE	4.48%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Tata Nifty MidSmall...	7.93
Motilal Oswal Nifty...	7.88
Nippon India Pharma...	6.07
ICICI Pru Nifty Pha...	5.93
Nippon India Nifty ...	5.92
HDFC Pharma and Hea...	5.60
Mirae Asset Healthc...	5.18

Risk Disclosures on Derivatives

Smart Quotes

LUPIN LTD.